Interferon-γ-deficient mice are resistant to the development of alopecia areata

British Journal of Dermatology

Volumn 155, Issue 3, 2006, Pages 515-521

  Freyschmidt Paul, P ^a   McElwee, K J ^a,b   Hoffmann, R ^a   Sundberg, J P ^c   Vitacolonna, M ^d   Kissling, S ^a   Zoller M ^d  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c JACKSON LABORATORY   (United States)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Alopecia areata; Autoimmunity; Experimental animal models; Hair follicle; Interferon ; T lymphocytes

Indexed keywords

AUTOANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ALOPECIA AREATA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE MODEL; FEMALE; FLOW CYTOMETRY; FULL THICKNESS SKIN GRAFT; GENE DELETION; IMMUNOHISTOCHEMISTRY; INTERFERON GAMMA GENE; LEUKOCYTE; LYMPH NODE CELL; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SKIN INFILTRATE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TISSUE SECTION; UPREGULATION;

ALOPECIA AREATA; ANIMALS; AUTOIMMUNE DISEASES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HAIR FOLLICLE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; INTERFERON TYPE II; INTERFERON-GAMMA; LYMPH NODES; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C3H; MICE, KNOCKOUT; SKIN; SKIN TRANSPLANTATION; TH1 CELLS; UP-REGULATION;

EID: 33745284006     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07377.x     Document Type: Article

References (26)

1. Paus R, Ito N, Takigawa M et al. The hair follicle and immune privilege. J Investig Dermatol Symp Proc 2003; 8:188-94.
2. Sundberg JP, Cordy WR, King LE Jr. Alopecia areata in aging C3H/HeJ mice. J Invest Dermatol 1994; 102:847-56.
3. Freyschmidt-Paul P, Sundberg JP, Happle R et al. Successful treatment of alopecia areata-like hair loss with the contact sensitizer squaric acid dibutylester (SADBE) in C3H/HeJ mice. J Invest Dermatol 1999; 113:61-8.
4. McElwee KJ, Hoffmann R, Freyschmidt-Paul P et al. Resistance to alopecia areata in C3H/HeJ mice is associated with increased expression of regulatory cytokines and a failure to recruit CD4+ and CD8+ cells. J Invest Dermatol 2002; 119:1426-33.
5. Zöller M, McElwee KJ, Engel P et al. Transient CD44 variant isoform expression and reduction in CD4(+)/CD25(+) regulatory T cells in C3H/HeJ mice with alopecia areata. J Invest Dermatol 2002; 118:983-92.
6. McElwee KJ, Freyschmidt-Paul P, Hoffmann R et al. Transfer of CD8(+) cells induces localized hair loss whereas CD4(+)/CD25(-) cells promote systemic alopecia areata and CD4(+)/CD25(+) cells blockade disease onset in the C3H/HeJ mouse model. J Invest Dermatol 2005; 124:947-57.
7. Freyschmidt-Paul P, McElwee KJ, Happle R et al. Interleukin-10-deficient mice are less susceptible to the induction of alopecia areata. J Invest Dermatol 2002; 119:980-2.
8. Freyschmidt-Paul P, McElwee KJ, Hoffmann R et al. Reduced expression of interleukin-2 decreases the frequency of alopecia areata onset in C3H/HeJ mice. J Invest Dermatol 2005; 125:945-51.
9. Gilhar A, Kam Y, Assy B et al. Alopecia areata induced in C3H/HeJ mice by interferon-gamma: evidence for loss of immune privilege. J Invest Dermatol 2005; 124:288-9.
10. Lucey DR, Clerici M, Shearer GM. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin Microbiol Rev 1996; 9:532-62.
11. Townsend MJ, McKenzie AN. Unravelling the net? Cytokines and diseases. J Cell Sci 2000; 113:3549-50.
12. Kaplan C, Valdez JC, Chandrasekaran R et al. Th1 and Th2 cytokines regulate proteoglycan-specific autoantibody isotypes and arthritis. Arthritis Res 2002; 4:54-8.
13. Hultgren B, Huang X, Dybdal N et al. Genetic absence of gamma-interferon delays but does not prevent diabetes in NOD mice. Diabetes 1996; 45:812-17.
14. Zhang GX, Xiao BG, Bai XF et al. Mice with IFN-gamma receptor deficiency are less susceptible to experimental autoimmune myasthenia gravis. J Immunol 1999; 162:3775-81.
15. Guedez YB, Whittington KB, Clayton JL et al. Genetic ablation of interferon-gamma up-regulates interleukin-1beta expression and enables the elicitation of collagen-induced arthritis in a nonsusceptible mouse strain. Arthritis Rheum 2001; 44:2413-24.
16. McElwee KJ, Boggess D, King LE et al. Experimental induction of alopecia areata-like hair loss in C3H/HeJ mice using full-thickness skin grafts. J Invest Dermatol 1998; 111:797-803.
17. Hoffmann R, Wenzel E, Huth A et al. Cytokine mRNA levels in alopecia areata before and after treatment with the contact allergen diphenylcyclopropenone. J Invest Dermatol 1994; 103:530-3.
18. Ito T, Ito N, Bettermann A et al. Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair follicle as a model. Am J Pathol 2004; 164:623-34.
19. Paus R, Christoph T, Müller-Röver S. Immunology of the hair follicle: a short journey into terra incognita. J Investig Dermatol Symp Proc 1999; 4:226-34.
20. Ruckert R, Hofmann U, van der Veen C et al. MHC class I expression in murine skin: developmentally controlled and strikingly restricted intraepithelial expression during hair follicle morphogenesis and cycling, and response to cytokine treatment in vivo. J Invest Dermatol 1998; 111:25-30.
21. Christoph T, Müller-Röver S, Audring H et al. The human hair follicle immune system: cellular composition and immune privilege. Br J Dermatol 2000; 142:862-73.
22. Limat A, Wyss-Coray T, Hunziker T et al. Comparative analysis of surface antigens in cultured human outer root sheath cells and epidermal keratinocytes: persistence of low expression of class I MHC antigens in outer root sheath cells in vitro. Br J Dermatol 1994; 131:184-90.
23. Schmidt-Weber CB, Blaser K. Regulation and role of transforming growth factor-beta in immune tolerance induction and inflammation. Curr Opin Immunol 2004; 16:709-16.
24. Roitt I, Brostoff J, Male D. Immunology, 5th edn. London: Mosby, 1998.
25. Carroll JM, McElwee KJ, King LE et al. Gene array profiling and immunomodulation studies define a cell-mediated immune response underlying the pathogenesis of alopecia areata in a mouse model and humans. J Invest Dermatol 2002; 119:392-402.
26. Dumont FJ. Fontolizumab Protein Design Labs. Curr Opin Investig Drugs 2005; 6:537-44.